Log in to save to my catalogue

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0e3e6c3ab9774848b67a0f077533e996

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

About this item

Full title

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2022-03, Vol.13 (1), p.1625-15, Article 1625

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The emergence of multidrug-resistant (MDR) Gram-negative pathogens is an urgent global medical challenge. The old polymyxin lipopeptide antibiotics (polymyxin B and colistin) are often the only therapeutic option due to resistance to all other classes of antibiotics and the lean antibiotic drug development pipeline. However, polymyxin B and colisti...

Alternative Titles

Full title

A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0e3e6c3ab9774848b67a0f077533e996

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0e3e6c3ab9774848b67a0f077533e996

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-022-29234-3

How to access this item